Search research articles
Contact Us
Filters
Showing results (151-160 of 154) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 154 results.
The New England Journal of Medicine
|
November 5, 2013
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias
J E Cortes, D-W Kim, J Pinilla-Ibarz, et al.
Leukemia
|
March 5, 2020
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
A Hochhaus, M Baccarani, R T Silver, et al.
Leukemia
|
October 27, 2015
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion
A Toma, O Kosmider, S Chevret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 20, 2011
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients
U Thiel, A Wawer, P Wolf, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 154) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 154 results.
The New England Journal of Medicine
|
November 5, 2013
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias
J E Cortes, D-W Kim, J Pinilla-Ibarz, et al.
Leukemia
|
March 5, 2020
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
A Hochhaus, M Baccarani, R T Silver, et al.
Leukemia
|
October 27, 2015
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion
A Toma, O Kosmider, S Chevret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 20, 2011
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients
U Thiel, A Wawer, P Wolf, et al.
Page
of 16